Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant for ACE inhibitor-induced angioedema
2009-015410-22Phase 2Completed
- Sponsor
- Technical University of Munich Faculty of Medicine
- Start
- Feb 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of icatibant in angiotensin-converting enzyme inhibitor-induced angioedema (ACEI-AE) (2 arms), sponsored by Technical University of Munich Faculty of Medicine. Primary endpoint: Time to complete symptom relief. Started Feb 2010; status: completed.
02
Drugs
icatibant
03
Conditions
angiotensin-converting enzyme inhibitor-induced angioedema (ACEI-AE)
Beyond the preview
Go deeper on 2009-015410-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015410-22.